“Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor”. Bipolar Disord11 (7): 726–34. (November 2009). doi:10.1111/j.1399-5618.2009.00757.x. hdl:10852/34620. PMID19839997.
“Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder”. Schizophr. Res.145 (1–3): 36–42. (April 2013). doi:10.1016/j.schres.2012.12.023. PMID23403415.
“Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment”. Neurobiol. Aging31 (11): 1877–84. (November 2010). doi:10.1016/j.neurobiolaging.2008.10.012. PMID19070941.
“Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease”. J. Alzheimers Dis.22 (4): 1305–11. (2010). doi:10.3233/JAD-2010-100921. PMID20930310.
“Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy”. J. Biol. Chem.280 (12): 11641–7. (2005). doi:10.1074/jbc.M411781200. PMID15659383.
“Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling”. J. Biol. Chem.272 (10): 6578–83. (1997). doi:10.1074/jbc.272.10.6578. PMID9045686.
“TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways”. Cell84 (2): 299–308. (1996). doi:10.1016/S0092-8674(00)80984-8. PMID8565075.
“Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation”. Immunity12 (3): 301–11. (2000). doi:10.1016/S1074-7613(00)80183-1. PMID10755617.
“A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase”. J. Biol. Chem.272 (9): 5861–70. (1997). doi:10.1074/jbc.272.9.5861. PMID9038203.
“A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'”. FEBS Lett.367 (1): 39–44. (1995). doi:10.1016/0014-5793(95)00534-G. PMID7601280.
“Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease”. J. Immunol.158 (9): 4252–9. (1997). doi:10.4049/jimmunol.158.9.4252. PMID9126987.
“TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex”. Immunity4 (4): 387–96. (1996). doi:10.1016/S1074-7613(00)80252-6. PMID8612133.
“Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP”. Oncogene19 (39): 4491–9. (2000). doi:10.1038/sj.onc.1203796. PMID11002422.
“The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis”. J. Biol. Chem.274 (15): 10145–53. (1999). doi:10.1074/jbc.274.15.10145. PMID10187798.
“Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin”. J. Immunol.157 (10): 4277–81. (1996). doi:10.4049/jimmunol.157.10.4277. PMID8906799.
“A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway”. Nat. Cell Biol.6 (2): 97–105. (2004). doi:10.1038/ncb1086. PMID14743216.
“hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activity”. FEBS Lett.425 (3): 431–5. (1998). doi:10.1016/S0014-5793(98)00287-7. PMID9563508.
“Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor”. Bipolar Disord11 (7): 726–34. (November 2009). doi:10.1111/j.1399-5618.2009.00757.x. hdl:10852/34620. PMID19839997.
“Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor”. Bipolar Disord11 (7): 726–34. (November 2009). doi:10.1111/j.1399-5618.2009.00757.x. hdl:10852/34620. PMID19839997.
“Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder”. Schizophr. Res.145 (1–3): 36–42. (April 2013). doi:10.1016/j.schres.2012.12.023. PMID23403415.
“Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment”. Neurobiol. Aging31 (11): 1877–84. (November 2010). doi:10.1016/j.neurobiolaging.2008.10.012. PMID19070941.
“Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease”. J. Alzheimers Dis.22 (4): 1305–11. (2010). doi:10.3233/JAD-2010-100921. PMID20930310.
“Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy”. J. Biol. Chem.280 (12): 11641–7. (2005). doi:10.1074/jbc.M411781200. PMID15659383.
“Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling”. J. Biol. Chem.272 (10): 6578–83. (1997). doi:10.1074/jbc.272.10.6578. PMID9045686.
“TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways”. Cell84 (2): 299–308. (1996). doi:10.1016/S0092-8674(00)80984-8. PMID8565075.
“Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation”. Immunity12 (3): 301–11. (2000). doi:10.1016/S1074-7613(00)80183-1. PMID10755617.
“Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells”. Cell Growth Differ.13 (1): 13–8. (2002). PMID11801527.
“A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase”. J. Biol. Chem.272 (9): 5861–70. (1997). doi:10.1074/jbc.272.9.5861. PMID9038203.
“A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'”. FEBS Lett.367 (1): 39–44. (1995). doi:10.1016/0014-5793(95)00534-G. PMID7601280.
“Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease”. J. Immunol.158 (9): 4252–9. (1997). doi:10.4049/jimmunol.158.9.4252. PMID9126987.
“TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex”. Immunity4 (4): 387–96. (1996). doi:10.1016/S1074-7613(00)80252-6. PMID8612133.
“Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP”. Oncogene19 (39): 4491–9. (2000). doi:10.1038/sj.onc.1203796. PMID11002422.
“The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis”. J. Biol. Chem.274 (15): 10145–53. (1999). doi:10.1074/jbc.274.15.10145. PMID10187798.
“Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin”. J. Immunol.157 (10): 4277–81. (1996). doi:10.4049/jimmunol.157.10.4277. PMID8906799.
“A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway”. Nat. Cell Biol.6 (2): 97–105. (2004). doi:10.1038/ncb1086. PMID14743216.
“hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activity”. FEBS Lett.425 (3): 431–5. (1998). doi:10.1016/S0014-5793(98)00287-7. PMID9563508.
